Lv4
690 积分 2025-10-02 加入
Drugs for Chronic Heart Failure
14天前
已关闭
A New Indication for Semaglutide (Wegovy)
14天前
已关闭
Forword for efficacy and safety of tirzepatide in patients with heart failure with preserved ejection fraction: A systematic review and meta-analysis
14天前
已关闭
Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT‐MMO trial
14天前
已完结
Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection Fraction
14天前
已完结
Reply
14天前
已关闭
Treatment of Metabolic (Dysfunction)-Associated Fatty Liver Disease: Evidence from Randomized Controlled Trials—A Short Review
14天前
已完结
Comparative Outcomes of Tirzepatide and Semaglutide in Patients With Heart Failure With Preserved Ejection Fraction and Type 2 Diabetes
14天前
已完结
Cardiology: What You May Have Missed in 2024
14天前
已完结
Comparative effectiveness of GLP-1 receptor agonists in patients with heart failure with preserved or minimally reduced ejection fraction: a comprehensive Bayesian network meta-analysis and network meta-regression
14天前
已关闭
皖公网安备34019202002308
